SAEM is a proud partner of the Providers Clinical Support System for Medications for Opioid Use Disorders (PCSS-MOUD) is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA). It is led by the American Academy of Addiction Psychiatry (AAAP) in collaboration with a wide coalition of national professional and health care organizations. PCSS-MOUD aims to increase the knowledge and skills of health care and counseling professionals about available evidence-based treatment approaches for substance use disorder (SUD) with a particular focus on opioid use disorder (OUD). PCSS-MOUD provides free training and mentoring to practitioners on the use of medications for OUD (MOUD) and the integration of these services into mainstream health care.
Podcast Available
EMS-Initiated Buprenorphine: Transforming Frontline Opioid Care
Speakers:
Nicholas Simpson, MD, is the chief medical director for Hennepin EMS in Minneapolis. He works as an emergency physician at HCMC in downtown Minneapolis. He is an associate medical director of the ECMO Program at Hennepin Healthcare. He is an associate professor of emergency medicine at the University of Minnesota.
Gerard G. Carroll, MD, EMT-P, is an associate professor of emergency medicine at Cooper University Health Care, where he leads the division of EMS and disaster medicine and directs the EMS Fellowship, with a focus on advancing prehospital care, addiction medicine, and physician field response.
Moderator: Gail D'Onofrio, MD, MS | Albert E. Kent Professor of Emergency Medicine | Yale University
Funding statement: Funding for this initiative was made possible (in part) by grant no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
GPRA Evaluation Survey
Please complete SAMHSA’s required Training and Technical Assistance (TTA) GPRA Post-Event Form. This form will gather participant demographic information and satisfaction with the event. Responses are anonymous.
Buprenorphine Prescribing for Pediatric Patients in the Emergency Department
Speakers:
Madeline Renny, MD, Assistant Professor of Emergency Medicine, Assistant Professor of Pediatrics and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai
Sarah Bagley, MD, MSc Associate Professor of Medicine and Pediatrics, Associate Program Director, Grayken Fellowship in Addiction Medicine Chobanian & Avedisian, Boston University School of Medicine
Moderator: Jennifer Love, MD | Assistant Professor | Mount Sinai School of Medicine
Funding statement: Funding for this initiative was made possible (in part) by grant no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
GPRA Evaluation Survey
Please complete SAMHSA’s required Training and Technical Assistance (TTA) GPRA Post-Event Form. This form will gather participant demographic information and satisfaction with the event. Responses are anonymous.
Practice-Based Guidelines:
Buprenorphine in the Age of Fentanyl
Upcoming Emergency Medicine Trainings
Mentorship
You can also find an emergency medicine mentor to help you with the unique experiences that emergency medicine professionals have with caring for patients with substance use disorders.
Find a Mentor Now
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.